These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8430183)

  • 1. Human brain tumors: assessment with in vivo proton MR spectroscopy.
    Ott D; Hennig J; Ernst T
    Radiology; 1993 Mar; 186(3):745-52. PubMed ID: 8430183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors.
    Bruhn H; Frahm J; Gyngell ML; Merboldt KD; Hänicke W; Sauter R; Hamburger C
    Radiology; 1989 Aug; 172(2):541-8. PubMed ID: 2748837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The proton MR spectroscopy of intracranial tumors. The differential diagnostic aspects for gliomas, metastases and meningiomas].
    Vogl TJ; Jassoy A; Söllner O; Becker C; Hamburger C; Dadashi A; Sauter R; Lissner J
    Rofo; 1992 Oct; 157(4):371-7. PubMed ID: 1327273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo hydrogen-1 magnetic resonance spectroscopy study of human intracranial tumors.
    Luan W; Zhang J
    Chin Med J (Engl); 1998 Jan; 111(1):56-8. PubMed ID: 10322655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short echo time MR spectroscopy of brain tumors: grading of cerebral gliomas by correlation analysis of normalized spectral amplitudes.
    Weis J; Ring P; Olofsson T; Ortiz-Nieto F; Wikström J
    J Magn Reson Imaging; 2010 Jan; 31(1):39-45. PubMed ID: 20027571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR image-guided P-31 MR spectroscopy in the evaluation of brain tumor treatment.
    Segebarth CM; Balériaux DF; Arnold DL; Luyten PR; den Hollander JA
    Radiology; 1987 Oct; 165(1):215-9. PubMed ID: 3628774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contribution of magnetic resonance spectrometry to the diagnosis of intracranial tumors].
    Galanaud D; Nicoli F; Le Fur Y; Roche P; Confort-Gouny S; Dufour H; Ranjeva JP; Peragut JC; Viout P; Cozzone PJ
    Ann Med Interne (Paris); 2002 Dec; 153(8):491-8. PubMed ID: 12610422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
    Tong Z; Yamaki T; Harada K; Houkin K
    Magn Reson Imaging; 2004 Jun; 22(5):735-42. PubMed ID: 15172069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical characterization of pediatric brain tumors by using in vivo and ex vivo magnetic resonance spectroscopy.
    Tzika AA; Cheng LL; Goumnerova L; Madsen JR; Zurakowski D; Astrakas LG; Zarifi MK; Scott RM; Anthony DC; Gonzalez RG; Black PM
    J Neurosurg; 2002 Jun; 96(6):1023-31. PubMed ID: 12066902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [1H magnetic resonance spectroscopy in intracranial tumors and cerebral ischemia].
    Felber SR
    Radiologe; 1993 Nov; 33(11):626-32. PubMed ID: 8278589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes.
    Gajewicz W; Papierz W; Szymczak W; Goraj B
    Med Sci Monit; 2003 Sep; 9(9):MT97-105. PubMed ID: 12960934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Magnetic resonance spectroscopy in gliomas].
    Galanaud D; Chinot O; Metellus P; Cozzone P
    Bull Cancer; 2005 Apr; 92(4):327-31. PubMed ID: 15888389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
    Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
    Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton MR spectroscopy in neoplastic and non-neoplastic brain disorders.
    Castillo M; Kwock L; Scatliff J; Mukherji SK
    Magn Reson Imaging Clin N Am; 1998 Feb; 6(1):1-20. PubMed ID: 9449737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of brain tumor with proton MR spectroscopy--the quantification of gliomas compared with normal brain].
    Yu HW; Tanabe S; Yamaki T; Harada K; Hashi K
    No Shinkei Geka; 2000 Dec; 28(12):1063-9. PubMed ID: 11193526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens.
    Cheng LL; Chang IW; Louis DN; Gonzalez RG
    Cancer Res; 1998 May; 58(9):1825-32. PubMed ID: 9581820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult brain tumors: clinical applications of magnetic resonance spectroscopy.
    Brandão LA; Castillo M
    Neuroimaging Clin N Am; 2013 Aug; 23(3):527-55. PubMed ID: 23928203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of 1H-magnetic resonance spectroscopy in differential diagnosis of brain low-grade gliomas and demyelinating diseases].
    Hou XY; Gao PY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):206-9. PubMed ID: 19507601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.